HGH Fragment 176-191 and MK-677 Interaction

Monitor
Mechanism-based 47% confidence

HGH Fragment 176-191 and MK-677 have an interaction requiring monitoring for interaction with 47% confidence. Both HGH Fragment 176-191 and MK-677 affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Both compounds affect the gi tract, so monitoring these systems is recommended.

Compound Profiles

HGH Fragment 176-191

Growth Hormone Fragment | Fat Loss Peptide

Mimics the lipolytic region of human growth hormone by stimulating fat breakdown through beta-3 adrenergic receptor pathways. Unlike full HGH, it does not bind the growth hormone receptor, so it does not increase IGF-1 levels or interfere with glucose metabolism.

Half-life: 15-20 minutes Typical dose: 250-500mcg weight loss, metabolic
carcinogenic riskinsulin disruptingteratogenic
View full profile

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Half-life: ~24 hours Typical dose: Start 12.5mg daily, increase to 25mg based on tolerance growth hormone, weight loss, sleep
ghrelin receptor blood pressure raisingcarcinogenic riskhepatotoxicinsulin disrupting
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low
Brain
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (HGH Fragment 176-191, MK-677). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (HGH Fragment 176-191, MK-677). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (HGH Fragment 176-191, MK-677). Monitor accordingly.

Frequently Asked Questions

Can I take HGH Fragment 176-191 with MK-677?

Yes, but with caution. Both HGH Fragment 176-191 and MK-677 affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is HGH Fragment 176-191 and MK-677 safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between HGH Fragment 176-191 and MK-677?

Both HGH Fragment 176-191 and MK-677 affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time HGH Fragment 176-191 and MK-677?

HGH Fragment 176-191 has a half-life of 15-20 minutes and MK-677 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: HGH Fragment 176-191 vs MK-677

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.